Commonwealth of Pa. v. Purdue Pharma
This text of Commonwealth of Pa. v. Purdue Pharma (Commonwealth of Pa. v. Purdue Pharma) is published on Counsel Stack Legal Research, covering Supreme Court of Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
IN THE SUPREME COURT OF PENNSYLVANIA EASTERN DISTRICT
COMMONWEALTH OF PENNSYLVANIA, : No. 26 EM 2022 ACTING BY AND THROUGH : PHILADELPHIA DISTRICT ATTORNEY : LAWRENCE S. KRASNER, : : Petitioner : : : v. : : : PURDUE PHARMA L.P., ET AL., : : Respondents : : CITY OF PHILADELPHIA, : : Petitioner : : : v. : : : ALLERGAN PLC, ET AL., : : Respondents : : CITY OF PHILADELPHIA, : : Petitioner : : : v. : : : PAR PHARMACEUTICAL, INC., ET AL., : : Respondents : : CITY OF PHILADELPHIA, : : Petitioner : : : v. : : : ALLERGAN LTD., ET AL., : : Respondents : : CITY OF PHILADELPHIA, : : Petitioner : : : v. : : : CVS INDIANA, LLC, ET AL., : : Respondents :
ORDER
PER CURIAM
AND NOW, this 9th day of September, 2022, the Application for Leave to Submit
Post-Submission Communication is GRANTED, and the “Application for Extraordinary
Relief under 42 Pa.C.S. §§502 and 726 and Pa.R.A.P. 3309” is DENIED.
[26 EM 2022] - 2
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
Commonwealth of Pa. v. Purdue Pharma, Counsel Stack Legal Research, https://law.counselstack.com/opinion/commonwealth-of-pa-v-purdue-pharma-pa-2022.